Maen Hussein
- Oncology top 1%
- Pulmonary and Respiratory Medicine top 1%
- Immunology top 5%
- Molecular Biology
- Cancer Research top 10%
- Co-authors
- Federico CappuzzoHenry Jacob ConterAlan SandlerNiels ReinmuthMarcin KowanetzDavey B. DanielMichael McCleodAlessandro Morabito
- Topics
- Cancer Immunotherapy and Biomarkers (25 papers)Lung Cancer Treatments and Mutations (19 papers)Lung Cancer Research Studies (16 papers)
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
Maen Hussein
44 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 75
- Oncology 2.5k
- Pulmonary and Respiratory Medicine 1.7k
- Immunology 642
- Molecular Biology 249
- Cancer Research 224
Countries citing papers authored by Maen Hussein
This map shows the geographic impact of Maen Hussein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maen Hussein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maen Hussein more than expected).
Fields of papers citing papers by Maen Hussein
This network shows the impact of papers produced by Maen Hussein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maen Hussein. The network helps show where Maen Hussein may publish in the future.
Co-authorship network of co-authors of Maen Hussein
This figure shows the co-authorship network connecting the top 25 collaborators of Maen Hussein. A scholar is included among the top collaborators of Maen Hussein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maen Hussein. Maen Hussein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 4 | |
| 5 | 15 | |
| 6 | 8 | |
| 7 | 0 | |
| 8 | 1 | |
| 9 | 1 | |
| 10 | Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non–Small-Cell Lung Cancer: The Phase III POSEIDON Studybreakdown → | 238 |
| 11 | Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected non-small-cell lung cancer (CITYSCAPE): primary and follow-up analyses of a randomised, double-blind, phase 2 studybreakdown → | 296 |
| 12 | 2 | |
| 13 | 19 | |
| 14 | 16 | |
| 15 | Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trialbreakdown → | 1137 |
| 16 | 1 | |
| 17 | 1 | |
| 18 | 39 | |
| 19 | 3 | |
| 20 | 2 |
About Maen Hussein
Maen Hussein is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Biological Psychiatry, having authored 46 papers that have together received 2.9k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (25 papers), Lung Cancer Treatments and Mutations (19 papers) and Lung Cancer Research Studies (16 papers). The work is most often cited by research in Oncology (2.5k citations), Pulmonary and Respiratory Medicine (1.7k citations) and Immunology (642 citations). Maen Hussein has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Federico Cappuzzo, Henry Jacob Conter, Alan Sandler, Niels Reinmuth, Marcin Kowanetz, Davey B. Daniel, Michael McCleod, Alessandro Morabito, Hans‐Georg Kopp and Tarek Mekhail. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.